logo-large
  • Browse Categories

Publications by authors named "Per Hammarlund"

Claim this Profile
S
Short and long-term efficacy of adalimumab in ulcerative colitis: a real-life study.
Leif Angelison, Sven Almer, Loa Davidsdottir, Per Hammarlund, Stefan Lindgren

Scand J Gastroenterol· February 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease.
Viktoria Bergqvist, Mohammad Kadivar, Daniel Molin, Leif Angelison, Per Hammarlund

Therap Adv Gastroenterol· October 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency.
Svein Oskar Frigstad, Anne Haaber, Antal Bajor, Jan Fallingborg, Per Hammarlund

Gastroenterol Res Pract· October 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.
Ragnar Befrits, Ola Wikman, Lars Blomquist, Henrik Hjortswang, Per Hammarlund

Scand J Gastroenterol· September 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: